Plenary

ISSCR 2018 Plenary and Concurrent

2 - EXPLOITING TARGETED (EPI)GENOME EDITING FOR THERAPEUTIC APPLICATIONS

6/22/2018
09:25 - 09:50

Angelo Lombardo

San Raffaele Telethon Institute for Gene Therapy, Italy

Angelo Lombardo (PhD) is Group Leader at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) and Assistant Professor of Tissue Biology at the Vita-Salute San Raffaele University, Milan, Italy. During his PhD and Postdoctoral studies, he significantly contributed to the field of targeted genome editing by developing innovative gene transfer technologies for the delivery of artificial nucleases, exploiting them in relevant disease models and characterizing their genome-wide specificity. His research now focuses on targeted epigenetic editing, a novel technology that exploits engineered transcriptional repressors to permanently silence genes of therapeutic relevance. His lab is also using these tools to study basic principles of gene regulation and transmission of epigenetic information.

Presentation(s):

Send Email for Angelo Lombardo


Assets

2 - EXPLOITING TARGETED (EPI)GENOME EDITING FOR THERAPEUTIC APPLICATIONS



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for EXPLOITING TARGETED (EPI)GENOME EDITING FOR THERAPEUTIC APPLICATIONS